BPC-157
COA published
A synthetic pentadecapeptide studied in in-vitro models of tissue-repair signalling and cellular migration.
From$54.00Select size
Thymosin Alpha-1
CAS62304-98-7
A thymic peptide investigated in immune-modulation and T-cell research.
- Test methods
- HPLC-UV + LC-MS
- Purity target
- 99%+ verified
- Sizes available
- 2
- Availability
- Backordered
Select size
Quantity
1
Total
$49.00
That's the price. No inflated list, no permanent “discount” code to make it look cheaper than it is.
Certificate for this lot is pending. Every batch we ship is published at /coa before it goes out.
For Research Use Only. Not for Human Consumption.
Products supplied by Synthrex Biotech LLC are intended strictly for in-vitro laboratory research and development by qualified professionals. They are not drugs, foods, cosmetics, or dietary supplements, and are not approved by the FDA for human or veterinary use. They are not sold for, and must not be used for, human or animal consumption or administration of any kind. Synthrex Biotech LLC is not a compounding pharmacy or chemical compounding facility as defined under section 503A of the Federal Food, Drug, and Cosmetic Act, and is not an outsourcing facility as defined under section 503B of that Act. By purchasing, you affirm that you are a qualified researcher acquiring these materials for lawful research purposes only. A Safety Data Sheet (SDS/MSDS) is available on request for every compound.
Sold by Synthrex Biotech LLC. A Safety Data Sheet (SDS) is available on request at support@synthrexbiotech.com.
✦ Research Notes
Background & literature
Origin
Thymosin alpha-1 is a 28-amino-acid peptide originally isolated from thymosin fraction 5, a thymic extract prepared by Allan Goldstein’s group in the 1970s during the effort to identify the thymus’s humoral factors. It was sequenced and synthesised, and — unusually for this catalog — it went on to genuine pharmaceutical development as thymalfasin, which is approved in a number of countries outside the United States. It remains not approved by the FDA.
What has been characterised
Characterised as an immunomodulatory peptide with described activity on T-cell maturation and on Toll-like receptor signalling in cell-culture and animal models. A 2001 review in the American Journal of Health-System Pharmacy covers the compound and its development; a 2025 review in the International Journal of Molecular Sciences addresses it in the context of ageing. The material supplied here is a research chemical, not the approved product sold elsewhere as thymalfasin, and it carries no approved indication in this form.
Sources
- 1.“Thymosin alpha-1.” Am J Health Syst Pharm, 2001. PMID 11381492
- 2.“Aging and Thymosin Alpha-1.” Int J Mol Sci, 2025. PMID 41373628
These notes are provided for scientific context only. They describe published laboratory and preclinical research and are not a claim of any effect in humans. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Batch releases & restocks
Know when the next batch is tested
We publish an independent certificate for every lot before it ships. Join the Lab List and we'll tell you when a new one lands and when a sold-out compound is back — plus 15% off your first order, shown on screen the second you join.
Batch and restock notices from Synthrex Biotech LLC. No dosing advice, ever. One-click unsubscribe on every email.
Related Compounds
TB-500
COA published
A thymosin beta-4 fragment investigated in research on cellular migration and angiogenesis pathways.
$50.00View
BPC-157 + TB-500 Blend
COA published
A combined preparation of BPC-157 and TB-500 used in comparative tissue-repair research models.
From$90.00Select size
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.